1.48
+0.29(+24.37%)
Currency In USD
| Previous Close | 1.19 |
| Open | 1.07 |
| Day High | 1.48 |
| Day Low | 1.07 |
| 52-Week High | 6.15 |
| 52-Week Low | 0.98 |
| Volume | 3.82M |
| Average Volume | 1.36M |
| Market Cap | 14.95M |
| PE | -0.42 |
| EPS | -3.54 |
| Moving Average 50 Days | 2.19 |
| Moving Average 200 Days | 2.36 |
| Change | 0.29 |
If you invested $1000 in Mangoceuticals, Inc. (MGRX) since IPO date, it would be worth $24.67 as of November 16, 2025 at a share price of $1.48. Whereas If you bought $1000 worth of Mangoceuticals, Inc. (MGRX) shares 1 year ago, it would be worth $635.19 as of November 16, 2025 at a share price of $1.48.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
GlobeNewswire Inc.
Nov 14, 2025 12:37 AM GMT
Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) is issuing the following clarification regarding its press release issued earlier this morning titled “Mangoceuticals Partners
Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management
GlobeNewswire Inc.
Nov 13, 2025 12:00 PM GMT
Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine pl
Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu
GlobeNewswire Inc.
May 27, 2025 1:00 PM GMT
Dallas, TX, May 27, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platfo